Evidence map›Paper›PMID 29355073›Full record

ArticleStatistical methods in medical research2019

Estimating causal log-odds ratio using the case-control sample and its application in the pharmaco-epidemiology study.

Anqi Zhu, Donglin Zeng, Pengyue Zhang, Lang Li

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anqi Zhu1 Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-3297-9642
Donglin Zeng1 Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Pengyue Zhang2 Center for Computational Biology and Bioinformatics, Department of Medical and Molecular Genetics, School of Medicine, Indiana University, Indianapolis, IN, USA.
Lang Li2 Center for Computational Biology and Bioinformatics, Department of Medical and Molecular Genetics, School of Medicine, Indiana University, Indianapolis, IN, USA.

Funding

Clinical Importance of Drug-Drug InteractionsR01AG025152 · NIA · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN, LI, LANG · 2006 to 2021
$8.1M
Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease ModelingR01NS073671 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2011 to 2025
$3.9M
Statistical and Machine Learning Methods to Improve Dynamic Treatment Regimens Estimation Using Real World Data.R01GM124104 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yuanjia Wang, Donglin Zeng · 2018 to 2026
$3.1M
Drug-Drug Interactions Involving Antidiabetic AgentsR01DK102694 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN, LI, LANG · 2014 to 2017
$2.4M
Evidence-based Drug-Interaction Discovery: In-Vivo, In-Vitro and ClinicalR01LM011945 · NLM · INDIANA UNIVERSITY INDIANAPOLIS · PI LI, LANG, ROCHA, LUIS M · 2014 to 2017
$1.8M
Bayesian Tools for PBPK Models in Drug Onteraction Res.R01GM074217 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI LI, LANG · 2005 to 2009
$1.3M
Integrated bioinformatic and pharmacokinetic models of high-dimensional drug interactionsR01GM117206 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI QUINNEY, SARA K · 2016 to 2018
$1.1M
NIA NIH HHS R01 AG025152NIDDK NIH HHS R01 DK102694NIGMS NIH HHS R01 GM074217NIGMS NIH HHS R01 GM117206NIGMS NIH HHS R01 GM124104NINDS NIH HHS R01 NS073671NLM NIH HHS R01 LM011945
6 · The paper itself

Abstract

One important goal in pharmaco-epidemiology studies is to understand the causal relationship between drug exposures and their clinical outcomes, including adverse drug events. In order to achieve this goal, however, we need to resolve several challenges. Most of pharmaco-epidemiology data are observational and confounding is largely present due to many co-medications. The pharmaco-epidemiology study data set is often sampled from large medical record databases using a matched case-control design, and it may not be representative of the original patient population in the medical record databases. Data analysis method needs to handle a large sample size that cannot be handled using existing statistical analysis packages. In this paper, we tackle these challenges both methodologically and computationally. We propose a conditional causal log-odds ratio (OR) definition to characterize causal effects of drug exposures on a binary adverse drug event adjusting for individual level confounders. Using a case-control design, we present a propensity score estimation using only case samples and we provide sufficient conditions for the consistency of the estimation of the causal log-odds ratio using case-based propensity scores. Computationally, we implement a principle component analysis to reduce high-dimensional confounders. Extensive simulation studies are performed to demonstrate superior performance of our method to existing methods. Finally, we apply the proposed method to analyze drug-induced myopathy data sampled from a de-identified subset of medical record database (close to 5 million patient records), The Indiana Network for Patient Care. Our method identified 70 drug-induced myopathy (

Indexed as

Drug-Related Side Effects and Adverse ReactionsEpidemiologic StudiesCase-Control StudiesCausalityDatabases, FactualHumansMedical RecordsOdds RatioPrescription DrugsPropensity ScorePrescription DrugsCase-control designcausal inferenceORpharmaco-epidemiologyprincipal componentspropensity scores

Identifiers

PMID29355073
PMCPMC6416084

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.